Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis

Citation
N. Knops et al., Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis, J RHEUMATOL, 26(9), 1999, pp. 2039-2043
Citations number
29
Categorie Soggetti
Rheumatology,"da verificare
Journal title
JOURNAL OF RHEUMATOLOGY
ISSN journal
0315162X → ACNP
Volume
26
Issue
9
Year of publication
1999
Pages
2039 - 2043
Database
ISI
SICI code
0315-162X(199909)26:9<2039:REEANS>2.0.ZU;2-S
Abstract
Objective. Undernutrition is frequently encountered in children with juveni le rheumatoid arthritis (JRA). We assessed resting energy expenditure (REE) in relation to nutritional status and body composition in patients with JR A. Methods. We selected 33 children (age 6 to 18 yrs) with JRA (13 oligoarticu lar, 10 polyarticular, 10 systemic JRA) and 17 controls matched for age and sex. Nutritional status was assessed for height, weight, and fat-free mass (FFM), and REE was measured with indirect calorimetry. Results. Nutritional status in the patients with systemic JRA was diminishe d compared to the controls for height (140 vs 159 cm; p < 0.01) and FFM (28 vs 38 kg; p = 0.03). Oligo and polyarticular patients with JRA had normal height and FFM. No significant differences existed in crude REE among the g roups. However, after correcting REE for body weight and FFM, the patients with systemic JRA, compared to controls, had 18% higher REE per kg body wei ght (159 vs 134 kJ/kg/day; p < 0.01) and 21% higher REE per kg FFM (196 vs 162 kJ/kg/day; p < 0.01). Oligo and polyarticular JRA patients had 8% incre ased values for REE per kg body weight or FFM, but these differences were n ot statistically significant. Conclusion. Patients with systemic TRA show stunting, low FFM, and a signif icantly increased REE when nutritional status is taken into account. These data suggest that assessment of individual energy requirements should inclu de correction for fat-free mass in the treatment of malnutrition in patient s with systemic JRA.